Morepen Labs. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
155.00
135.00
55.00
126.00
98.00
39.00
Adjustment
37.00
34.00
27.00
19.00
31.00
36.00
Changes In working Capital
-123.00
-58.00
-158.00
-181.00
-78.00
-58.00
Cash Flow after changes in Working Capital
69.00
111.00
-74.00
-35.00
52.00
16.00
Cash Flow from Operating Activities
32.00
73.00
-91.00
-60.00
50.00
11.00
Cash Flow from Investing Activities
-321.00
-83.00
-46.00
-31.00
-70.00
-12.00
Cash Flow from Financing Activities
299.00
5.00
143.00
66.00
47.00
5.00
Net Cash Inflow / Outflow
10.00
-4.00
5.00
-25.00
27.00
4.00
Opening Cash & Cash Equivalents
16.00
21.00
15.00
41.00
13.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
27.00
16.00
21.00
15.00
41.00
13.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Morepen Labs.
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
155.11
-75.36
230.00
305.83%
Adjustment
37.79
183.64
-146.00
-79.42%
Changes In working Capital
-123.69
2.78
-125.00
-4549.28%
Cash Flow after changes in Working Capital
69.21
111.06
-42.00
-37.68%
Cash Flow from Operating Activities
32.06
94.93
-62.00
-66.23%
Cash Flow from Investing Activities
-321.51
-339.11
18.00
5.19%
Cash Flow from Financing Activities
299.89
241.42
58.00
24.22%
Net Cash Inflow / Outflow
10.44
-2.76
12.00
478.26%
Opening Cash & Cash Equivalents
16.95
14.86
2.00
14.06%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
27.38
12.1
15.00
126.28%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -56.30% vs 180.48% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
32.06
73.37
-56.30%






